Search results for "Pancreatic"

showing 10 items of 545 documents

Disconnected pancreatic duct syndrome: complete pancreas transection secondary to acute pancreatitis

2016

Disconnected pancreatic duct syndrome is a serious complication of acute pancreatitis which is defined by a complete discontinuity of the pancreatic duct, such that a viable side of the pancreas remains isolated from the gastrointestinal tract. This pancreatic disruption is infrequently observed in the clinical practice and its diagnostic and therapeutic management are controversial. We present an extreme case of disconnected pancreatic duct syndrome with complete duct disruption and pancreatic transection following acute pancreatitis, as well as the diagnostic and therapeutic processes carried out.

medicine.medical_specialtyPancreatic pseudocysteducation030230 surgeryGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumanslcsh:RC799-869PancreasPancreatic ductCholangiopancreatography Endoscopic RetrogradeGastrointestinal tractbusiness.industryGastroenterologyPancreatic DuctsGeneral MedicineMiddle Agedmedicine.diseaseAdenocarcinoma MucinousMagnetic Resonance ImagingPancreatic Neoplasmsmedicine.anatomical_structurePancreatitisAcute pancreatitisPancreatitis030211 gastroenterology & hepatologyFemalelcsh:Diseases of the digestive system. GastroenterologybusinessPancreasComplicationTomography X-Ray ComputedDuct (anatomy)Revista Espanola de Enfermedades Digestivas
researchProduct

In Vivo Molecular Imaging of Somatostatin Receptors in Pancreatic Islet Cells and Neuroendocrine Tumors by Miniaturized Confocal Laser-Scanning Fluor…

2010

The aim of the study was to evaluate real time in vivo molecular imaging of somatostatin receptors (sstrs) using a handheld miniaturized confocal laser scan microscope (CLM) in conjunction with fluorescein-labeled octreotate (OcF) in healthy mice and murine models of neuroendocrine tumors. For CLM a small rigid probe (diameter 7 mm) with an integrated single line laser (488 nm) was used (optical slice thickness 7 μm; lateral resolution 0.7 μm). OcF was synthesized via Fmoc solid-phase peptide synthesis and purified by HPLC showing high-affinity binding to the sstr2 (IC50 6.2 nmol). For in vitro evaluation, rat and human pancreatic cancer cells were used and characterized with respect to its…

medicine.medical_specialtyPathologyConfocalEndocrinology Diabetes and MetabolismClinical BiochemistryMice NudeNeuroendocrine tumorsOctreotideBinding CompetitiveBiochemistryIslets of LangerhansMiceEndocrinologyIn vivoInternal medicinePancreatic cancerCell Line TumormedicineSomatostatin receptor 2AnimalsHumansReceptors SomatostatingeographyMice Inbred BALB Cgeography.geographical_feature_categoryMicroscopy ConfocalMiniaturizationChemistrySomatostatin receptorReverse Transcriptase Polymerase Chain ReactionGene Expression ProfilingBiochemistry (medical)Reproducibility of Resultsmedicine.diseaseIsletFluoresceinsImmunohistochemistryMolecular ImagingNeuroendocrine TumorsEndocrinologyEx vivoThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Molecular imaging of gastroenteropancreatic neuroendocrine tumors.

2010

Somatostatin-receptor scintigraphy has become an obligatory molecular imaging method in the management of patients with neuroendocrine tumors when metastatic disease is suspected. Using positron emission tomography and new somatostatin analogues, sensitivity of somatostatin receptor imaging has further increased. With a combination of morphologic imaging methods, such as hybrid imaging by PET/CT, this method represents the method of choice in many centers and efforts are under way to translate somatostatin receptor imaging onto a cellular level by endoscopic confocal microscopy. Other clinically relevant functional pathways in neuroendocrine tumors that are accessible by PET imaging are glu…

medicine.medical_specialtyPathologyNeuroendocrine tumorsScintigraphylaw.inventionConfocal microscopylawmedicineHumansReceptors SomatostatinGastrointestinal NeoplasmsMicroscopy Confocalmedicine.diagnostic_testbusiness.industrySomatostatin receptorGastroenterologyPet imagingmedicine.diseaseCarcinoma NeuroendocrineMolecular ImagingPancreatic NeoplasmsNeuroendocrine TumorsSomatostatinPositron emission tomographyPositron-Emission TomographyRadiologyMolecular imagingRadiopharmaceuticalsbusinessGastroenterology clinics of North America
researchProduct

Common and uncommon pitfalls in pancreatic imaging: it is not always cancer.

2015

Despite advances in multimodality imaging of pancreas, there is still overlap between imaging findings of several pancreatic/peripancreatic disease processes. Pancreatic and peripancreatic non-neoplastic entities may mimic primary pancreatic neoplasms on ultrasound, CT, and MRI. On the other hand, primary pancreatic cancer may be overlooked on imaging because of technical and inherent factors. The purpose of this pictorial review is to describe and illustrate pancreatic imaging pitfalls and highlight the basic radiological features for proper differential diagnosis.

medicine.medical_specialtyPathologyUrologyDifferential diagnosiComputed tomographyMultimodal Imaging030218 nuclear medicine & medical imagingDiagnosis Differential03 medical and health sciencesMagnetic resonance imaging0302 clinical medicinePancreatic cancermedicineHumansRadiology Nuclear Medicine and imagingComputed tomographyMultimodal imagingRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryPancreatic NeoplasmGastroenterologyCancerPancreatic DiseasesMagnetic resonance imagingmedicine.diseaseDiagnostic errorPancreatic Neoplasmsmedicine.anatomical_structure030220 oncology & carcinogenesisRadiologyPancreatic DiseaseDifferential diagnosisPancreasbusinessHumanAbdominal radiology (New York)
researchProduct

2006

medicine.medical_specialtyPathologybusiness.industryGeneral Physics and AstronomyCell BiologyIn situ hybridizationLiver carcinomaStructural BiologyMolecular geneticsImmunohistochemistryMedicineGeneral Materials SciencePancreatic carcinomabusinessMicron
researchProduct

Docetaxel as Salvage Therapy in Highly Pretreated and Drug Resistant Gastrointestinal Carcinomas

2008

Introduction Despite many efforts to develop new chemotherapies for metastatic upper gastrointestinal (GI) cancer, overall prognosis continues to be fatal, particularly in gastric and pancreatic cancer. Many of these patients deserve second-or third-line treatment after failure of first-line chemotherapy. Therefore, we analysed toxicity and response rate of weekly docetaxel after failed upfront regimes in these upper GI cancer patients. Patients and Methods Between 2001 and 2006, 18 patients received docetaxel based regimes (35 mg/m2 weekly) after informed consent. Response rates were determined using RECIST criteria or tumor progression if clinically evident. Toxicities were graded based o…

medicine.medical_specialtyPathologymedicine.medical_treatmentSalvage therapyNeutropeniachemotherapygastriclcsh:RC254-282GastroenterologysalvageInternal medicinePancreatic cancermedicinedocetaxelOriginal ResearchChemotherapyLeukopeniabusiness.industryCancerlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasemetastaticRegimenOncologyDocetaxelmedicine.symptombusinessmedicine.drugClinical medicine. Oncology
researchProduct

Is preoperative radiographic localization of islet cell tumors in patients with insulinoma necessary?

1993

Preoperative localization tests [sonography, computed tomography, angiography, percutaneous transhepatic portal venous sampling for insulin radioimmunoassay (PTP)] have a sensitivity of 60% to 90% in cases of organic hyperinsulinism. In all publications, however, the sensitivity of intraoperative localization, 75% to 100%, is distinctly higher. With the exception of PTP, all tumors that can be identified by preoperative localization can also be detected using palpation or intraoperative sonography. Preoperative localization diagnosis is therefore not absolutely necessary prior to primary operation in the case of organic hyperinsulinism. It is requested by many surgeons because: (1) only a f…

medicine.medical_specialtyPercutaneousmedicine.diagnostic_testbusiness.industryRadiographyMagnetic resonance imagingmedicine.diseaseMagnetic Resonance ImagingSensitivity and SpecificityPalpationPancreatic NeoplasmsAngiographymedicineHumansInsulinomaSurgeryRadiologyTomography X-Ray ComputedbusinessHyperinsulinismInsulinomaUltrasonographyAbdominal surgeryWorld Journal of Surgery
researchProduct

An unusual case of postcholecystectomy syndrome.

2019

medicine.medical_specialtyPostcholecystectomy syndromemedicine.medical_treatmentMEDLINEYoung AdultImaging Three-DimensionalPancreaticobiliary MaljunctionmedicineHumansRadiology Nuclear Medicine and imagingCholangiopancreatography Endoscopic RetrogradeUnusual casemedicine.diagnostic_testbusiness.industryGeneral surgeryGastroenterologyCystic DuctMagnetic resonance imagingmedicine.diseaseMagnetic Resonance ImagingCholecystectomy LaparoscopicCholedochal CystCholecystectomyFemalebusinessPostcholecystectomy SyndromeGastrointestinal endoscopy
researchProduct

Hat das Ausmaß der Lymphknotendissektion einen Einfluß auf die Morbidität und Prognose nach Pankreaskopfresektion wegen eines duktalen oder periampul…

1997

We examined the influence of lymph node dissection on morbidity and mortality of 13 patients after resection of the head of pancreas due to a ductal or periampullary carcinoma. In both groups the radicality of the operation was the main prognostic factor. In ductal pancreatic carcinoma the R-status was able to be determined better by normalisation of the postoperative Ca 19-9 serum level than by the evaluation of the surgeon or pathologist. For prognosis, the quotient of metastatic lymph nodes to resected lymph nodes indicates that an extensive lymph node dissection may increase the long term survival. A lymph node dissection is therefore to be recommended, especially since it does not incr…

medicine.medical_specialtyPrognostic factorbusiness.industryGeneral surgeryHead of pancreasResectionDissectionmedicine.anatomical_structuremedicineSurgeryLymphRadiologyPancreatic carcinomaPancreasbusinessLymph nodeLangenbecks Archiv für Chirurgie
researchProduct

Rate of Post-Operative Pancreatic Fistula after Robotic-Assisted Pancreaticoduodenectomy with Pancreato-Jejunostomy versus Pancreato-Gastrostomy: A R…

2021

Background: Different techniques of pancreatic anastomosis have been described, with inconclusive results in terms of pancreatic fistula reduction. Studies comparing robotic pancreaticogastrostomy (PG) and pancreaticojejunostomy (PJ) are scarcely reported. Methods: The present study analyzes the outcomes of two case-matched groups of patients who underwent PG (n = 20) or PJ (n = 40) after pancreaticoduodenectomy. The primary aim was to compare the rate of post-operative pancreatic fistula. Results: Operative time (375 vs. 315 min, p = 0.34), estimated blood loss (270 vs. 295 mL, p = 0.44), and rate of clinically relevant post-operative pancreatic fistula (12.5% vs. 10%, p = 0.82) were simil…

medicine.medical_specialtyRobotic assistedmedicine.medical_treatmentAnastomosisArticlerobotic pancreatic surgery03 medical and health sciences0302 clinical medicinepancreatic fistulaBlood lossMedicinePost operativebusiness.industryRGeneral MedicinePancreaticoduodenectomymedicine.diseaseGastrostomySurgeryPancreatic fistulapancreato-gastrostomy030220 oncology & carcinogenesisJejunostomyMedicine030211 gastroenterology & hepatologybusinessJournal of Clinical Medicine
researchProduct